Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

SECRETIN-FERRING

SECRETIN

Standard Dose
75CU/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SECRETIN-FERRING is listed in Drugs@FDA under application 018290 (NDA).

Marketing status: Discontinued Active ingredient SECRETIN Form and strength INJECTABLE;INJECTION - 75CU/VIAL Sponsor FERRING Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview SECRETIN-FERRING is listed in Drugs@FDA under application 018290 (NDA). Marketing status: Discontinued Active ingredient SECRETIN Form and strength INJECTABLE;INJECTION - 75CU/VIAL Sponsor FERRING Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
SECRETIN-FERRING (SECRETIN) | Drug Monograph | MedicHelpline